Super-responders to bidirectional neoadjuvant chemotherapy showed prolonged survival.
Super-responders to bidirectional neoadjuvant chemotherapy showed prolonged survival.
- 2021
English
2078-6891
10.21037/jgo-2020-11 [doi] jgo-12-S1-S57 [pii] PMC8100712 [pmc]
IN PROCESS -- NOT YET INDEXED
Washington Cancer Institute
Comment
Editorial
English
2078-6891
10.21037/jgo-2020-11 [doi] jgo-12-S1-S57 [pii] PMC8100712 [pmc]
IN PROCESS -- NOT YET INDEXED
Washington Cancer Institute
Comment
Editorial